US$ 28.58
bpc 157 clinical trial recruiting The Stable Gastric Pentadecapeptide Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC-157 + TB-500 Blend Peptide
Description
doi: 10.1136/bjsm.2006.034447

Autoimmune mechanisms in type 1 diabetes

In animal-model studies, BPC-157 administration has been associated with increased VEGF expression and enhanced vascularisation in target tissues

It is derived from the C-terminal region of human growth hormone, specifically amino acids 176 to 191, with an additional tyrosine residue at the N-terminus
